|
US2490813A
(en)
|
1944-11-29 |
1949-12-13 |
Standard Oil Co |
Continuous process for making aryl amines
|
|
US3299078A
(en)
|
1962-10-01 |
1967-01-17 |
Smith Kline French Lab |
Pyrido [3', 4': 4, 5] pyrrolo [3, 2, 1-hi] indoles and-[3, 2, 1-ij] quinolines
|
|
US3813392A
(en)
|
1969-06-09 |
1974-05-28 |
J Sellstedt |
Pyrrolo(1,2,3-alpha epsilon)quinoxalin-2(3h)-ones and related compounds
|
|
US4115577A
(en)
|
1972-06-19 |
1978-09-19 |
Endo Laboratories, Inc. |
Pyridopyrrolobenzheterocycles
|
|
US3914421A
(en)
|
1972-06-19 |
1975-10-21 |
Endo Lab |
Pyridopyrrolobenzheterocycles for combatting depression
|
|
US4238607A
(en)
|
1972-06-19 |
1980-12-09 |
Endo Laboratories Inc. |
Pyridopyrrolo benzheterocycles
|
|
US4183936A
(en)
|
1972-06-19 |
1980-01-15 |
Endo Laboratories, Inc. |
Pyridopyrrolobenzheterocycles
|
|
US4001263A
(en)
|
1974-04-01 |
1977-01-04 |
Pfizer Inc. |
5-Aryl-1,2,3,4-tetrahydro-γ-carbolines
|
|
IE41352B1
(en)
|
1974-04-01 |
1979-12-19 |
Pfizer |
5-aryl-1,2,3,4-tetrahydro- -carbolines
|
|
JPS6032638B2
(ja)
|
1976-09-01 |
1985-07-29 |
武田薬品工業株式会社 |
３−アミノピラゾロ〔３，４−ｄ〕ピリミジン誘導体
|
|
US4219550A
(en)
|
1978-11-09 |
1980-08-26 |
E. I. Du Pont De Nemours And Company |
Cis- and trans- octahydropyridopyrrolobenzheterocycles
|
|
US4389330A
(en)
|
1980-10-06 |
1983-06-21 |
Stolle Research And Development Corporation |
Microencapsulation process
|
|
IE52535B1
(en)
|
1981-02-16 |
1987-12-09 |
Ici Plc |
Continuous release pharmaceutical compositions
|
|
EP0077372A1
(de)
|
1981-04-22 |
1983-04-27 |
Byk Gulden Lomberg Chemische Fabrik GmbH |
NEUE PYRAZOLO(3,4-d)PYRIMIDINE, VERFAHREN ZU DEREN HERSTELLUNG UND SIE ENTHALTENDE ARZNEIMITTEL
|
|
US4469868A
(en)
|
1982-05-24 |
1984-09-04 |
Warner-Lambert Company |
Alkylimidazo[1,2-c]pyrazolo[3,4-e]pyrimidines
|
|
US4530840A
(en)
|
1982-07-29 |
1985-07-23 |
The Stolle Research And Development Corporation |
Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents
|
|
US4522944A
(en)
|
1982-12-23 |
1985-06-11 |
Erba Farmitalia |
Carboxamido-derivatives of 5H-1,3,4-thiadiazolo[3,2-a]pyrimidines, compositions and use
|
|
CH656884A5
(de)
|
1983-08-26 |
1986-07-31 |
Sandoz Ag |
Polyolester, deren herstellung und verwendung.
|
|
US4722810A
(en)
|
1984-08-16 |
1988-02-02 |
E. R. Squibb & Sons, Inc. |
Enkephalinase inhibitors
|
|
EP0136883B1
(en)
|
1983-10-03 |
1987-11-25 |
E.R. Squibb & Sons, Inc. |
Enkephalinase inhibitors
|
|
US4666908A
(en)
|
1985-04-05 |
1987-05-19 |
Warner-Lambert Company |
5-Substituted pyrazolo[4,3-d]pyrimidine-7-ones and methods of use
|
|
EP0238059B1
(en)
|
1986-03-19 |
1993-06-16 |
Kumiai Chemical Industry Co., Ltd. |
5H-1,3,4-Thiazole[3,2-a]pyrimidin-5-one derivatives and fungicidal compositions containing the same
|
|
DE3786365T2
(de)
|
1986-04-07 |
1993-10-21 |
Ihara Chemical Ind Co |
5H-1,3,4-Thiadiazolo[3,2-a]pyrimidin-5-on-Derivate und diese enthaltende Gartenbau- und landwirtschaftliche Fungizidmittel.
|
|
US4929641B1
(en)
|
1988-05-11 |
1994-08-30 |
Schering Corp |
Mercapto-acylamino acid antihypertensives
|
|
KR880007441A
(ko)
|
1986-12-11 |
1988-08-27 |
알렌 제이.스피겔 |
스피로-치환된 글루타르아미드 이뇨제
|
|
HU208484B
(en)
|
1988-08-17 |
1993-11-29 |
Chinoin Gyogyszer Es Vegyeszet |
Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia
|
|
GB8820844D0
(en)
|
1988-09-05 |
1988-10-05 |
Pfizer Ltd |
Therapeutic agents
|
|
US5114976A
(en)
|
1989-01-06 |
1992-05-19 |
Norden Michael J |
Method for treating certain psychiatric disorders and certain psychiatric symptoms
|
|
US5538739A
(en)
|
1989-07-07 |
1996-07-23 |
Sandoz Ltd. |
Sustained release formulations of water soluble peptides
|
|
KR920004437B1
(ko)
|
1989-09-12 |
1992-06-05 |
삼성전자 주식회사 |
금전등록기의 거래선 관리방법
|
|
WO1991009840A1
(en)
|
1989-12-22 |
1991-07-11 |
Schering Corporation |
Mercaptocycloacyl aminoacid endopeptidase inhibitors
|
|
NZ238609A
(en)
|
1990-06-21 |
1993-12-23 |
Schering Corp |
Polycyclic guanine derivatives; preparation, pharmaceutical compositions,
|
|
US5202328A
(en)
|
1991-03-06 |
1993-04-13 |
Merck & Co., Inc. |
Substituted fused pyrimidinones
|
|
AU1870292A
(en)
|
1991-04-16 |
1992-11-17 |
Schering Corporation |
Use of neutral endopeptidase inhibitors in the treatment of nephrotoxicity
|
|
FI922867A7
(fi)
|
1991-06-21 |
1992-12-22 |
Tanabe Seiyaku Co |
Dikarbonsyraderivat och foerfarande foer framstaellning av dem
|
|
GB9123353D0
(en)
|
1991-11-04 |
1991-12-18 |
Fujisawa Pharmaceutical Co |
New mercapto-amide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
|
|
US5217996A
(en)
|
1992-01-22 |
1993-06-08 |
Ciba-Geigy Corporation |
Biaryl substituted 4-amino-butyric acid amides
|
|
US5294612A
(en)
|
1992-03-30 |
1994-03-15 |
Sterling Winthrop Inc. |
6-heterocyclyl pyrazolo [3,4-d]pyrimidin-4-ones and compositions and method of use thereof
|
|
RU2124503C1
(ru)
|
1992-05-18 |
1999-01-10 |
И.Р.Сквибб энд Санз, Инк. |
Гетероциклические азотсодержащие производные карбоновой кислоты, способ их получения и фармацевтическая композиция
|
|
JPH06199850A
(ja)
|
1992-12-28 |
1994-07-19 |
Tanabe Seiyaku Co Ltd |
インドール含有ペプチド及びその製法
|
|
WO1994015908A1
(fr)
|
1993-01-14 |
1994-07-21 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Derive de propionamide et son utilisation medicinale
|
|
US5939419A
(en)
|
1993-02-26 |
1999-08-17 |
Schering-Plough Corporation |
2-benzyl-polycyclic guanine derivatives and process for preparing them
|
|
GB9304919D0
(en)
|
1993-03-10 |
1993-04-28 |
Celltech Ltd |
Chemical compounds
|
|
IT1271352B
(it)
|
1993-04-08 |
1997-05-27 |
Boehringer Ingelheim Italia |
Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale
|
|
GB9315017D0
(en)
|
1993-07-20 |
1993-09-01 |
Glaxo Lab Sa |
Chemical compounds
|
|
CN1074923C
(zh)
|
1993-11-19 |
2001-11-21 |
詹森药业有限公司 |
微囊密封的3-哌啶基取代的1,2-苯并异唑类和1,2-苯并异噻唑类
|
|
US6221335B1
(en)
|
1994-03-25 |
2001-04-24 |
Isotechnika, Inc. |
Method of using deuterated calcium channel blockers
|
|
US6334997B1
(en)
|
1994-03-25 |
2002-01-01 |
Isotechnika, Inc. |
Method of using deuterated calcium channel blockers
|
|
US5576460A
(en)
|
1994-07-27 |
1996-11-19 |
Massachusetts Institute Of Technology |
Preparation of arylamines
|
|
KR100376150B1
(ko)
|
1994-11-04 |
2003-11-01 |
산텐 세이야꾸 가부시키가이샤 |
히드록시기를함유하는1,3-디알킬우레아유도체
|
|
DE19510566A1
(de)
|
1995-03-23 |
1996-09-26 |
Kali Chemie Pharma Gmbh |
Benzazepin-, Benzoxazepin- und Benzothiazepin-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
|
|
GB9523675D0
(en)
|
1995-11-20 |
1996-01-24 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
US5824683A
(en)
|
1995-11-28 |
1998-10-20 |
Schering Corporation |
2'- 4'-halo- 1,1'-biphenyl!-4-yl!methyl!-5'-methyl-spiro cyclopentane-1,7' (8'H)- 3H! imidazo 2,1-b!purin!-4' (5'H)-ones
|
|
GB9526245D0
(en)
|
1995-12-21 |
1996-02-21 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
US5648542A
(en)
|
1996-02-29 |
1997-07-15 |
Xerox Corporation |
Arylamine processes
|
|
US5654482A
(en)
|
1996-02-29 |
1997-08-05 |
Xerox Corporation |
Triarylamine processes
|
|
US5648539A
(en)
|
1996-02-29 |
1997-07-15 |
Xerox Corporation |
Low temperature arylamine processes
|
|
DE19638020A1
(de)
|
1996-09-18 |
1998-03-19 |
Solvay Pharm Gmbh |
Die gastrointestinale Durchblutung fördernde Arzneimittel
|
|
US5847166A
(en)
|
1996-10-10 |
1998-12-08 |
Massachusetts Institute Of Technology |
Synthesis of aryl ethers
|
|
GB9622363D0
(en)
|
1996-10-28 |
1997-01-08 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
EP0946523A1
(en)
|
1996-12-23 |
1999-10-06 |
Celltech Therapeutics Limited |
Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors
|
|
US5723671A
(en)
|
1997-01-30 |
1998-03-03 |
Xerox Corporation |
Arylamine processes
|
|
US5723669A
(en)
|
1997-01-30 |
1998-03-03 |
Xerox Corporation |
Arylamine processes
|
|
US5705697A
(en)
|
1997-01-30 |
1998-01-06 |
Xerox Corporation |
Arylamine processes
|
|
TWI242011B
(en)
|
1997-03-31 |
2005-10-21 |
Eisai Co Ltd |
1,4-substituted cyclic amine derivatives
|
|
SE9701398D0
(sv)
|
1997-04-15 |
1997-04-15 |
Astra Pharma Prod |
Novel compounds
|
|
IT1291372B1
(it)
|
1997-05-21 |
1999-01-07 |
Schering Plough S P A |
Uso di analoghi eterociclici di 1,2,4-triazolo (1,5-c) pirimidine per la preparazione di medicamenti utili per il trattamento delle malattie
|
|
US6323366B1
(en)
|
1997-07-29 |
2001-11-27 |
Massachusetts Institute Of Technology |
Arylamine synthesis
|
|
GB2328686B
(en)
|
1997-08-25 |
2001-09-26 |
Sankio Chemical Co Ltd |
Method for producing arylamine
|
|
WO1999018057A1
(en)
|
1997-10-06 |
1999-04-15 |
Massachusetts Institute Of Technology |
Preparation of diaryl ether by condensation reactions
|
|
US6013621A
(en)
|
1997-10-17 |
2000-01-11 |
The Rockfeller University |
Method of treating psychosis and/or hyperactivity
|
|
GB9722520D0
(en)
|
1997-10-24 |
1997-12-24 |
Pfizer Ltd |
Compounds
|
|
ATE229499T1
(de)
|
1998-02-26 |
2002-12-15 |
Massachusetts Inst Technology |
Metallkatalysierte arylierungen und vinylierungen von hydrazinen, hydrazonen, hydroxylaminen und oximen
|
|
US6235936B1
(en)
|
1998-02-26 |
2001-05-22 |
Massachusetts Institute Of Technology |
Metal-catalyzed arylations of hydrazines, hydrazones, and related substrates
|
|
EP1067123B1
(en)
|
1998-03-31 |
2011-01-19 |
Kyowa Hakko Kirin Co., Ltd. |
Nitrogenous heterocyclic compounds
|
|
US5902901A
(en)
|
1998-05-07 |
1999-05-11 |
Xerox Corporation |
Arylamine processes
|
|
US6133273A
(en)
|
1998-05-08 |
2000-10-17 |
American Home Products Corporation |
Pyrazolopyrimidine-2,4-dione sulfonamides
|
|
CA2336691C
(en)
|
1998-07-10 |
2009-02-10 |
Massachusetts Institute Of Technology |
Ligands for metals and metal-catalyzed processes
|
|
US7223879B2
(en)
|
1998-07-10 |
2007-05-29 |
Massachusetts Institute Of Technology |
Ligands for metals and improved metal-catalyzed processes based thereon
|
|
US6307087B1
(en)
|
1998-07-10 |
2001-10-23 |
Massachusetts Institute Of Technology |
Ligands for metals and improved metal-catalyzed processes based thereon
|
|
US6395916B1
(en)
|
1998-07-10 |
2002-05-28 |
Massachusetts Institute Of Technology |
Ligands for metals and improved metal-catalyzed processes based thereon
|
|
US20010008942A1
(en)
|
1998-12-08 |
2001-07-19 |
Buchwald Stephen L. |
Synthesis of aryl ethers
|
|
US6440710B1
(en)
|
1998-12-10 |
2002-08-27 |
The Scripps Research Institute |
Antibody-catalyzed deuteration, tritiation, dedeuteration or detritiation of carbonyl compounds
|
|
PT1140012E
(pt)
|
1998-12-17 |
2004-05-31 |
Alza Corp |
Conversao de capsulas de gelatina cheias com liquido em sistemas de libertacao controlada por camadas multiplas
|
|
GB9907658D0
(en)
|
1999-04-06 |
1999-05-26 |
Zeneca Ltd |
Chemical compounds
|
|
AR023574A1
(es)
|
1999-04-23 |
2002-09-04 |
Pharmacia & Upjohn Co Llc |
Compuestos de azepinindol tetraciclico,composiciones farmaceuticas y el uso de dichos compuestos para preparar un medicamento, e intermediarios
|
|
US6407092B1
(en)
|
1999-04-23 |
2002-06-18 |
Pharmacia & Upjohn Company |
Tetracyclic azepinoindole compounds
|
|
US6713471B1
(en)
|
1999-06-15 |
2004-03-30 |
Bristol-Myers Squibb Pharma Company |
Substituted heterocycle fused gamma-carbolines
|
|
ATE277048T1
(de)
|
1999-06-15 |
2004-10-15 |
Bristol Myers Squibb Pharma Co |
Substituierte hetercyclisch kondensierte gamma carboline
|
|
US7071186B2
(en)
|
1999-06-15 |
2006-07-04 |
Bristol-Myers Squibb Pharma Co. |
Substituted heterocycle fused gamma-carbolines
|
|
EP1194152A4
(en)
|
1999-06-30 |
2002-11-06 |
Merck & Co Inc |
Links to SRC kinase inhibition
|
|
WO2001000213A1
(en)
|
1999-06-30 |
2001-01-04 |
Merck & Co., Inc. |
Src kinase inhibitor compounds
|
|
DE19931206A1
(de)
|
1999-07-07 |
2001-01-11 |
Stief Christian |
Arzneimittel zur Erhöhung des cAMP-Spiegels und deren Verwendung
|
|
AU779908B2
(en)
|
1999-09-10 |
2005-02-17 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
CA2379585C
(en)
|
1999-09-30 |
2006-06-20 |
James W. Darrow |
Certain alkylene diamine-substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines
|
|
HK1049834A1
(zh)
|
1999-10-11 |
2003-05-30 |
辉瑞大药厂 |
用作磷酸二酯酶抑制剂的5-(2-取代的-5-杂环基磺酰基吡啶-3-基)-二氢吡唑并[4，3-d]嘧啶-7-酮类化合物
|
|
TWI265925B
(en)
|
1999-10-11 |
2006-11-11 |
Pfizer |
Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them
|
|
IL139073A0
(en)
|
1999-10-21 |
2001-11-25 |
Pfizer |
Treatment of neuropathy
|
|
IL139457A0
(en)
|
1999-11-08 |
2001-11-25 |
Pfizer |
Compounds for the treatment of female sexual dysfunction
|
|
PT1104760E
(pt)
|
1999-12-03 |
2003-06-30 |
Pfizer Prod Inc |
Compostos de sulfamoil-heteroarilpirazole como agentes analgesicos e anti-inflamatorios
|
|
MY125533A
(en)
|
1999-12-06 |
2006-08-30 |
Bristol Myers Squibb Co |
Heterocyclic dihydropyrimidine compounds
|
|
GB0004890D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
|
US20020006926A1
(en)
|
2000-04-19 |
2002-01-17 |
Roylance H. H. |
Use of cyclic GMP-specific phosphodiesterase inhibitors for treatment of parkinson's disease
|
|
US20020028799A1
(en)
|
2000-07-06 |
2002-03-07 |
Naylor Alasdair Mark |
Treatment of male sexual dysfunction
|
|
US6541639B2
(en)
|
2000-07-26 |
2003-04-01 |
Bristol-Myers Squibb Pharma Company |
Efficient ligand-mediated Ullmann coupling of anilines and azoles
|
|
US6693099B2
(en)
|
2000-10-17 |
2004-02-17 |
The Procter & Gamble Company |
Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
|
|
US6849619B2
(en)
|
2000-12-20 |
2005-02-01 |
Bristol-Myers Squibb Company |
Substituted pyridoindoles as serotonin agonists and antagonists
|
|
SK7042003A3
(en)
|
2000-12-20 |
2004-07-07 |
Bristol Myers Squibb Co |
Substituted pyridoindoles as serotonin agonists and antagonists
|
|
WO2002074312A1
(en)
|
2001-03-16 |
2002-09-26 |
Pfizer Limited |
Pyrazolo`4,3-d.pyrimidinone compounds as cgmp pde inhibitors
|
|
US20030032579A1
(en)
|
2001-04-20 |
2003-02-13 |
Pfizer Inc. |
Therapeutic use of selective PDE10 inhibitors
|
|
KR20030092107A
(ko)
|
2001-04-24 |
2003-12-03 |
메사추세츠 인스티튜트 오브 테크놀로지 |
탄소-헤테로원자 및 탄소-탄소 결합을 형성하는 구리-촉매방법
|
|
WO2002088079A2
(en)
|
2001-05-01 |
2002-11-07 |
Bristol-Myers Squibb Company |
Dual inhibitors of pde 7 and pde 4
|
|
SE0102315D0
(sv)
|
2001-06-28 |
2001-06-28 |
Astrazeneca Ab |
Compounds
|
|
CA2453537A1
(en)
|
2001-08-08 |
2003-02-20 |
Pharmacia & Upjohn Company |
Therapeutic 1h-pyrido¬4,3-b|indoles
|
|
ATE395349T1
(de)
|
2001-08-28 |
2008-05-15 |
Schering Corp |
Polycyclische guanin phosphodiesterase inhibitoren
|
|
IL160307A0
(en)
|
2001-08-31 |
2004-07-25 |
Univ Rockefeller |
Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain
|
|
CA2465893A1
(en)
|
2001-11-09 |
2003-05-22 |
Schering Corporation |
Polycyclic guanine derivative phosphodiesterase v inhibitors
|
|
EP1314554A1
(fr)
|
2001-11-23 |
2003-05-28 |
Kba-Giori S.A. |
Dispositif de décollage d'éléments de sécurité
|
|
AU2003219770B2
(en)
|
2002-02-15 |
2008-10-09 |
Merckle Gmbh |
Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
|
|
IL163575A0
(en)
|
2002-02-21 |
2005-12-18 |
Univ Rockefeller |
Compositions and method for regulation of calcium-dependent signalling in brain
|
|
NZ570198A
(en)
|
2002-07-29 |
2010-01-29 |
Alza Corp |
Methods and dosage forms for controlled delivery of paliperidone or risperidone
|
|
US20050232995A1
(en)
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
|
AU2003257062A1
(en)
|
2002-08-02 |
2004-02-23 |
Massachusetts Institute Of Technology |
Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
|
|
GB0230045D0
(en)
|
2002-12-23 |
2003-01-29 |
Glaxo Group Ltd |
Compounds
|
|
AU2003276009A1
(en)
|
2002-10-01 |
2004-04-23 |
Bayer Healthcare Ag |
Regulation of human 3', 5' cyclic nucleotide phosphodiesterase pde1c
|
|
US7223870B2
(en)
|
2002-11-01 |
2007-05-29 |
Pfizer Inc. |
Methods for preparing N-arylated oxazolidinones via a copper catalyzed cross coupling reaction
|
|
AU2003287433A1
(en)
|
2002-11-01 |
2004-06-07 |
Oregon Health And Science University |
Treatment of hyperkinetic movement disorder with donepezil
|
|
TW200413273A
(en)
|
2002-11-15 |
2004-08-01 |
Wako Pure Chem Ind Ltd |
Heavy hydrogenation method of heterocyclic rings
|
|
WO2004056324A2
(en)
|
2002-12-19 |
2004-07-08 |
Bristol-Myers Squibb Company |
Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists
|
|
US20070155662A1
(en)
|
2003-03-11 |
2007-07-05 |
Stefan Golz |
Diagnostics and therapeutics for diseases associated with phosphodiesterase 1a (pde1a)
|
|
EP1613747A1
(en)
|
2003-03-31 |
2006-01-11 |
Pfizer Products Inc. |
Crystal structure of 3 ,5 -cyclic nucleotide phosphodiesterase 1b (pde1b) and uses thereof
|
|
US7153824B2
(en)
|
2003-04-01 |
2006-12-26 |
Applied Research Systems Ars Holding N.V. |
Inhibitors of phosphodiesterases in infertility
|
|
ATE411980T1
(de)
|
2003-07-21 |
2008-11-15 |
Smithkline Beecham Corp |
(2s,4s)-4-fluor-1-ä4-fluor-beta-(4-fluorphenyl) l-phenylalanylü-2-pyrrolidincarbonitril-p- toluolsulfonsäuresalz und wasserfreie kristalline formen davon
|
|
AR045582A1
(es)
|
2003-09-05 |
2005-11-02 |
Neurogen Corp |
Piridinas pirazinas y pirimidinas heteroarilo fusionadas como ligandos receptores de crf1
|
|
JP2005259113A
(ja)
|
2004-02-12 |
2005-09-22 |
Ricoh Co Ltd |
プロセス編集装置、プロセス管理装置、プロセス編集プログラム、プロセス管理プログラム、記録媒体、プロセス編集方法及びプロセス管理方法
|
|
WO2005095396A1
(en)
|
2004-03-05 |
2005-10-13 |
Pharma C S.A. |
8-phenoxy-ϝ carboline derivatives
|
|
US20050222209A1
(en)
|
2004-04-01 |
2005-10-06 |
Zeldis Jerome B |
Methods and compositions for the treatment, prevention or management of dysfunctional sleep and dysfunctional sleep associated with disease
|
|
US7592454B2
(en)
|
2004-04-14 |
2009-09-22 |
Bristol-Myers Squibb Company |
Substituted hexahydro-pyridoindole derivatives as serotonin receptor agonists and antagonists
|
|
CA2574081A1
(en)
|
2004-07-19 |
2006-02-23 |
University Of Florida Research Foundation, Inc. |
Methods and materials for treating mental illness
|
|
CA2580619C
(en)
|
2004-09-20 |
2013-11-12 |
Mount Sinai School Of Medicine |
Use of memantine (namenda) to treat autism, compulsivity, and impulsivity
|
|
JP2008513432A
(ja)
|
2004-09-21 |
2008-05-01 |
ファイザー・プロダクツ・インク |
Ｃｎｓ状態の治療に有用なｎ−メチルヒドロキシエチルアミン
|
|
US7614727B2
(en)
|
2004-09-30 |
2009-11-10 |
Fujifilm Corporation |
Liquid ejection head, manufacturing method thereof, and image forming apparatus
|
|
ATE457989T1
(de)
|
2004-12-15 |
2010-03-15 |
Hoffmann La Roche |
Bi- und trizyklische substituierte phenyl- methanone als inhibitoren von glycin-i (glyt-1)- transportern zur behandlung der alzheimer- krankheit
|
|
EP1848433A2
(en)
|
2005-01-25 |
2007-10-31 |
Celgene Corporation |
Methods and compositions using 4-amino-2-(3-methyl-2,6-dioxopiperidin-3-yl)-isoindole-1-3-dione
|
|
AU2006255028B2
(en)
|
2005-06-06 |
2012-04-19 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
US20080194592A1
(en)
|
2005-08-23 |
2008-08-14 |
Intra-Cellular Therapies, Inc. |
Organic Compounds
|
|
DE102005042877A1
(de)
|
2005-09-09 |
2007-03-22 |
Bayer Healthcare Ag |
Inhibition der PDE1A
|
|
EP1934201A1
(en)
|
2005-10-06 |
2008-06-25 |
Auspex Pharmaceuticals Inc. |
Deuterated inhibitors of gastric h+, k+-atpase with enhanced therapeutic properties
|
|
EP1940389A2
(en)
|
2005-10-21 |
2008-07-09 |
Braincells, Inc. |
Modulation of neurogenesis by pde inhibition
|
|
US7645752B2
(en)
|
2006-01-13 |
2010-01-12 |
Wyeth Llc |
Sulfonyl substituted 1H-indoles as ligands for the 5-hydroxytryptamine receptors
|
|
US7750168B2
(en)
|
2006-02-10 |
2010-07-06 |
Sigma-Aldrich Co. |
Stabilized deuteroborane-tetrahydrofuran complex
|
|
KR20090042227A
(ko)
|
2006-06-06 |
2009-04-29 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
유기 화합물
|
|
US20070286890A1
(en)
|
2006-06-07 |
2007-12-13 |
John Garnett Walt |
Eyelash applicator and method
|
|
AU2007292848A1
(en)
|
2006-09-08 |
2008-03-13 |
Braincells, Inc. |
Combinations containing a 4-acylaminopyridine derivative
|
|
WO2008063505A1
(en)
|
2006-11-13 |
2008-05-29 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
WO2008070095A1
(en)
|
2006-12-05 |
2008-06-12 |
Intra-Cellular Therapies, Inc. |
Novel uses
|
|
KR102107954B1
(ko)
|
2007-03-12 |
2020-05-07 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
치환된 헤테로환 융합 감마-카르볼린 합성
|
|
RS52166B
(sr)
|
2007-05-11 |
2012-08-31 |
Pfizer Inc. |
Amino-heterociklična jedinjenja
|
|
MX2010001218A
(es)
|
2007-08-01 |
2010-04-07 |
Medivation Neurology Inc |
Metodos y composiciones para tratamiento contra esquizofrenia mediante uso de terapia combinada de agentes antipsicoticos.
|
|
JP5393677B2
(ja)
|
2007-08-15 |
2014-01-22 |
アリーナ ファーマシューティカルズ， インコーポレイテッド |
５−ＨＴ２Ａセロトニン受容体に関連した障害の治療のための５−ＨＴ２Ａセロトニン受容体のモジュレーターとしてのイミダゾ［１，２−ａ］ピリジン誘導体
|
|
KR20120012831A
(ko)
|
2007-12-06 |
2012-02-10 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
유기 화합물
|
|
EP2240028B1
(en)
|
2007-12-06 |
2016-07-20 |
Intra-Cellular Therapies, Inc. |
Pyrazolopyrimidine-4,6-dione derivatives and their use as pharmaceutical
|
|
NZ586963A
(en)
|
2008-02-05 |
2012-11-30 |
Clera Inc |
Use of dopamine d2 receptor inhibitors for alleviating depression or improving cognition
|
|
AU2009223701B2
(en)
|
2008-03-12 |
2015-04-16 |
Intra-Cellular Therapies, Inc. |
Substituted heterocycle fused gamma-carbolines solid
|
|
CA2723372A1
(en)
|
2008-05-05 |
2009-11-12 |
University Of Rochester |
Methods and compositions for the treatment or prevention of pathological cardiac remodeling and heart failure
|
|
EP3085231A1
(en)
|
2008-05-27 |
2016-10-26 |
Intra-Cellular Therapies, Inc. |
Method and compositions for sleep disorders and other disorders
|
|
US20120070443A1
(en)
|
2008-12-02 |
2012-03-22 |
University Of Utah Research Foundation |
Pde1 as a target therapeutic in heart disease
|
|
BRPI0922809A2
(pt)
|
2008-12-06 |
2018-05-29 |
Intracellular Therapies Inc |
compostos orgânicos
|
|
EP2367431B1
(en)
|
2008-12-06 |
2015-08-05 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
MA32942B1
(fr)
|
2008-12-06 |
2012-01-02 |
Intra Cellular Therapies Inc |
Composes organiques
|
|
KR20110103949A
(ko)
|
2008-12-06 |
2011-09-21 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
유기 화합물
|
|
JP5778582B2
(ja)
|
2008-12-06 |
2015-09-16 |
イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． |
有機化合物
|
|
EP2367430B1
(en)
|
2008-12-06 |
2014-08-13 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
WO2010098839A1
(en)
|
2009-02-25 |
2010-09-02 |
Intra-Cellular Therapies, Inc. |
Pde 1 inhibitors for ophthalmic disorders
|
|
JP2012526810A
(ja)
|
2009-05-13 |
2012-11-01 |
イントラ−セルラー・セラピーズ・インコーポレイテッド |
有機化合物
|
|
JP6166534B2
(ja)
|
2009-08-05 |
2017-07-19 |
イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． |
新規調節タンパク質および阻害剤
|
|
WO2011043816A1
(en)
|
2009-10-08 |
2011-04-14 |
Intra-Cellular Therapies, Inc. |
Phosphodiesterase 1-targeting tracers and methods
|
|
CA2796756A1
(en)
|
2010-04-22 |
2011-10-27 |
Intra-Cellular Therapies, Inc. |
Substituted pyrido(3',4':4,5)pyrrolo(1,2,3-de)quinoxalines for the treatment of central nervous system disorders
|
|
WO2011153136A1
(en)
|
2010-05-31 |
2011-12-08 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
EP2576551A4
(en)
|
2010-05-31 |
2014-04-16 |
Intra Cellular Therapies Inc |
ORGANIC CONNECTIONS
|
|
TW201206937A
(en)
|
2010-05-31 |
2012-02-16 |
Intra Cellular Therapies Inc |
Organic compounds
|
|
WO2011153135A1
(en)
|
2010-05-31 |
2011-12-08 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
JP5959074B2
(ja)
|
2011-05-31 |
2016-08-02 |
セラヴァンス バイオファーマ アール＆ディー アイピー， エルエルシー |
ネプリライシン阻害剤
|
|
JP6051210B2
(ja)
|
2011-06-10 |
2016-12-27 |
イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． |
有機化合物
|
|
JP2014525927A
(ja)
|
2011-08-18 |
2014-10-02 |
シャイアー アーゲー |
治療法に使用される５−ｈｔ４受容体アゴニスト及びｐｄｅ４阻害剤の組合せ
|
|
KR20140146192A
(ko)
|
2012-04-14 |
2014-12-24 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
유기 화합물
|
|
WO2013184898A1
(en)
|
2012-06-08 |
2013-12-12 |
Theravance, Inc. |
Neprilysin inhibitors
|
|
AR091507A1
(es)
|
2012-06-21 |
2015-02-11 |
Intra Cellular Therapies Inc |
SALES DE (6aR,9aS)-5,6a,7,8,9,9a-HEXAHIDRO-5-METIL-3-(FENILAMINO)-2-((4-(6-FLUOROPIRIDIN-2-IL)FENIL)METIL)-CICLOPENT[4,5]IMIDAZO[1,2-a]PIRAZOLO[4,3-e]PIRIMIDIN-4(2H)-ONA
|
|
US10011602B2
(en)
|
2012-07-06 |
2018-07-03 |
The University Of Melbourne |
Immunological reagents and uses therefor
|
|
AR092568A1
(es)
|
2012-09-14 |
2015-04-22 |
Abbvie Deutschland |
Derivados triciclicos de quinolinas y de quinoxalinas
|
|
US9801882B2
(en)
|
2013-02-17 |
2017-10-31 |
Intra-Cellular Therapies, Inc. |
Phosphodiesterase-1 inhibitors and their use in treatment of cardiovascular diseases
|
|
US9708322B2
(en)
|
2013-03-15 |
2017-07-18 |
Intra-Cellular Therapies, Inc. |
Substituted pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalines for inhibiting serotonin reuptake transporter activity
|
|
EP2968338B1
(en)
|
2013-03-15 |
2019-01-09 |
Intra-Cellular Therapies, Inc. |
Pde1 inhibitors for use in the treatment and/or prevention of cns injuries, and pns diseases, disorders or injuries
|
|
KR102240326B1
(ko)
*
|
2013-03-15 |
2021-04-13 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
유기 화합물
|
|
KR102373288B1
(ko)
|
2013-12-03 |
2022-03-10 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
신규한 방법
|
|
JP6696904B2
(ja)
*
|
2014-01-08 |
2020-05-20 |
イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． |
製剤および医薬組成物
|
|
CA2944755A1
(en)
|
2014-04-04 |
2015-10-08 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
US10077267B2
(en)
|
2014-04-04 |
2018-09-18 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
WO2015191554A1
(en)
|
2014-06-09 |
2015-12-17 |
Intra-Cellular Therapies, Inc. |
Compounds and methods of use to treat schizophrenia
|
|
EP3157926B1
(en)
|
2014-06-20 |
2019-05-15 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
US10285992B2
(en)
|
2014-08-07 |
2019-05-14 |
Intra-Cellular Therapies, Inc. |
Combinations of PDE1 inhibitors and NEP inhibitors and associated methods
|
|
US10131671B2
(en)
|
2014-08-07 |
2018-11-20 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
AU2016272089B2
(en)
|
2015-06-03 |
2021-02-18 |
Triastek, Inc. |
Dosage forms and use thereof
|
|
PL3838274T3
(pl)
|
2016-01-26 |
2024-04-02 |
Intra-Cellular Therapies, Inc. |
Pochodna pirydo[3',4':4,5]pirolo[1,2,3-DE]chinoksaliny do zastosowania w leczeniu zaburzeń OUN
|
|
DK3407889T3
(da)
|
2016-03-25 |
2021-08-09 |
Intra Cellular Therapies Inc |
Organiske forbindelser og deres anvendelse til behandling og forebyggelse af lidelser i centralnervesystemet
|
|
US20200392135A1
(en)
|
2016-03-25 |
2020-12-17 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
JP7134168B6
(ja)
*
|
2016-09-12 |
2024-02-02 |
イントラ－セルラー・セラピーズ・インコーポレイテッド |
新規使用
|
|
WO2019178484A1
(en)
*
|
2018-03-16 |
2019-09-19 |
Intra-Cellular Therapies, Inc. |
Novel methods
|